ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04110	Cell cycle	4/10	145/7206	3.00663434653e-05
ko05206	MicroRNAs in cancer	4/10	177/7206	6.58271740787e-05
ko04218	Cellular senescence	4/10	177/7206	6.58271740787e-05
ko05222	Small cell lung cancer	3/10	89/7206	0.00020528952693
ko05215	Prostate cancer	3/10	111/7206	0.000394556232537
ko05161	Hepatitis B	3/10	173/7206	0.00144124151736
ko05224	Breast cancer	3/10	174/7206	0.00146544636908
ko05219	Bladder cancer	2/10	48/7206	0.00188983671923
ko05200	Pathways in cancer	4/10	492/7206	0.00323590295034
ko05223	Non-small cell lung cancer	2/10	66/7206	0.00354608918832
ko04115	p53 signaling pathway	2/10	74/7206	0.00443886609396
ko05214	Glioma	2/10	79/7206	0.00504463506557
ko05212	Pancreatic cancer	2/10	83/7206	0.00555536287516
ko05220	Chronic myeloid leukemia	2/10	85/7206	0.00581935560301
ko05218	Melanoma	2/10	85/7206	0.00581935560301
ko05166	HTLV-I infection	3/10	292/7206	0.0063918902126
ko05162	Measles	2/10	120/7206	0.0113406170801
ko01522	Endocrine resistance	2/10	124/7206	0.012076672658
ko04919	Thyroid hormone signaling pathway	2/10	143/7206	0.015853549125
ko04310	Wnt signaling pathway	2/10	181/7206	0.0247294473775
ko04390	Hippo signaling pathway	2/10	188/7206	0.0265465459093
ko05167	Kaposi's sarcoma-associated herpesvirus infection	2/10	191/7206	0.0273419310793
ko05216	Thyroid cancer	1/10	34/7206	0.0462218639561